000 | 02005 a2200565 4500 | ||
---|---|---|---|
005 | 20250515034649.0 | ||
264 | 0 | _c20061205 | |
008 | 200612s 0 0 eng d | ||
022 | _a0007-1250 | ||
024 | 7 |
_a10.1192/bjp.bp.105.013045 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPost, R M | |
245 | 0 | 0 |
_aMood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. _h[electronic resource] |
260 |
_bThe British journal of psychiatry : the journal of mental science _cAug 2006 |
||
300 |
_a124-31 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdjuvants, Pharmaceutic _xadverse effects |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAffect |
650 | 0 | 4 |
_aAntidepressive Agents _xadverse effects |
650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xadverse effects |
650 | 0 | 4 |
_aBipolar Disorder _xdrug therapy |
650 | 0 | 4 |
_aBupropion _xadverse effects |
650 | 0 | 4 |
_aCyclohexanols _xadverse effects |
650 | 0 | 4 |
_aDepressive Disorder _xchemically induced |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSertraline _xadverse effects |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aVenlafaxine Hydrochloride |
700 | 1 | _aAltshuler, L L | |
700 | 1 | _aLeverich, G S | |
700 | 1 | _aFrye, M A | |
700 | 1 | _aNolen, W A | |
700 | 1 | _aKupka, R W | |
700 | 1 | _aSuppes, T | |
700 | 1 | _aMcElroy, S | |
700 | 1 | _aKeck, P E | |
700 | 1 | _aDenicoff, K D | |
700 | 1 | _aGrunze, H | |
700 | 1 | _aWalden, J | |
700 | 1 | _aKitchen, C M R | |
700 | 1 | _aMintz, J | |
773 | 0 |
_tThe British journal of psychiatry : the journal of mental science _gvol. 189 _gp. 124-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1192/bjp.bp.105.013045 _zAvailable from publisher's website |
999 |
_c16469237 _d16469237 |